Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001178913-24-002029
Filing Date
2024-06-20
Accepted
2024-06-20 16:42:12
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A zk2431587.htm DEFA14A 38490
2 image00002.jpg GRAPHIC 2309
  Complete submission text file 0001178913-24-002029.txt   42879
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38556 | Film No.: 241057113
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)